Programmable RNA Therapeutics

Our Company

CircNova, Inc. is a biotechnology company that leverages our unique AI NovaEngine™ to generate, analyze and identify circular RNA for therapeutic development.

Our experts focus on non-coding RNA with many mechanisms of action against undruggable disease targets for major unmet clinical needs.

CircNova is developing a robust IP portfolio for development of circRNA therapeutics.

Our Vision

We are driven by our passion to innovate, discover and lead the development of life-changing RNA based therapies.
We offer partners and patients new solutions to previously undruggable targets that lead to better quality of life.

World's first circRNA 3D structure modeled with deep-learning

Our Technology

Generative Artificial Intelligence has arrived to deliver novel applications in drug discovery, gene therapy, and biotechnology.

AI-guided RNA-folding and active structure prediction coupled with high-throughput RNA synthesis enables revolutionary efficiencies in effective development of therapeutic candidates.

Our AI NovaEngine™ is the first in the world to predict circular RNA structures using deep-learning, allowing unprecedented capability in therapeutic design for "undruggable" diseases, such as Triple-negative Breast Cancer.

Our Mission

We realize our aspiration through investment in continuous AI learning activities, novel data generation and NovaEngine™ pipeline growth.

Our value is bolstered by innovative engagement and cutting-edge discoveries through key partnerships and collaborations with top research institutions.

Our culture is built upon the collective strength of our diversity, expertise and receptivity as leaders.

Our future is shaped by a shared experience of inclusivity and the superior performance of our industry-leading team and technology.